Back to PCVX
D. E. Shaw & Co., Inc. PCVX Position History
Vaxcyte, Inc. • Healthcare
Quarters held
17
Latest value
$368K
Q2 2026
Peak value
$161.7M
First seen
Q4 2022
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2022 | $46.6M |
| Q4 2023 | $27.5M |
| Q1 2024 | $25.1M |
| Q2 2024 | $17.4M |
| Q3 2024 | $48.4M |
| Q4 2024 | $63.5M |
| Q1 2025 | $32.8M |
| Q2 2025 | $99.9M |
| Q2 2025 | $548K |
| Q3 2025 | $152.5M |
| Q3 2025 | $2.1M |
| Q4 2025 | $159.9M |
| Q4 2025 | $7.6M |
| Q1 2026 | $161.7M |
| Q1 2026 | $4.8M |
| Q2 2026 | $110.2M |
| Q2 2026 | $368K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $368K | 6.3K | — | — |
| Q2 2026 | $110.2M | 1.90M | — | — |
| Q1 2026 | $4.8M | 82.9K | — | — |
| Q1 2026 | $161.7M | 2.78M | — | — |
| Q4 2025 | $7.6M | 165.0K | — | — |
| Q4 2025 | $159.9M | 3.47M | — | — |
| Q3 2025 | $2.1M | 57.2K | — | — |
| Q3 2025 | $152.5M | 4.23M | — | — |
| Q2 2025 | $548K | 16.8K | — | — |
| Q2 2025 | $99.9M | 3.07M | — | — |
| Q1 2025 | $32.8M | 867.9K | — | — |
| Q4 2024 | $63.5M | 775.7K | — | — |
| Q3 2024 | $48.4M | 423.5K | — | — |
| Q2 2024 | $17.4M | 230.2K | — | — |
| Q1 2024 | $25.1M | 367.2K | — | — |
| Q4 2023 | $27.5M | 438.3K | — | — |
| Q4 2022 | $46.6M | 972.3K | — | — |
Other funds holding PCVX
$356.8M
$311.1M
$311.1M
$258M
$238.6M
$93.8M
$83.9M